Thrombosis risk factors

Citations 1-10 of 10 total displayed.

Most recent content (1 Jun 2008):

Original Articles
Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System

Muhannad Masoud, Galit Sarig, Benjamin Brenner, and Giris Jacob
Hypertension 51: 1545 -1551; published online before print as doi:10.1161/HYPERTENSIONAHA.108.112003 [Abstract] [Full text]  

Past content (since Feb 2003):

Scientific Contributions
Orthostatic Hypercoagulability. A Novel Physiological Mechanism to Activate the Coagulation System

Muhannad Masoud, Galit Sarig, Benjamin Brenner, and Giris Jacob
Hypertension published April 14, 2008, doi:10.1161/HYPERTENSIONAHA.108.112003 [Abstract]  

Scientific Contributions
Determinants of Platelet Activation in Human Essential Hypertension

Pietro Minuz, Paola Patrignani, Stefania Gaino, Francesca Seta, Marta L. Capone, Stefania Tacconelli, Maurizio Degan, Giovanni Faccini, Anna Fornasiero, Giorgio Talamini, Rosamaria Tommasoli, Enrico Arosio, Clara Lechi Santonastaso, Alessandro Lechi, and Carlo Patrono
Hypertension 43: 64 -70; published online before print as doi:10.1161/01.HYP.0000105109.44620.1B [Abstract] [Full text]  

Scientific Contributions
Determinants of Platelet Activation in Human Essential Hypertension

Pietro Minuz, Paola Patrignani, Stefania Gaino, Francesca Seta, Marta L. Capone, Stefania Tacconelli, Maurizio Degan, Giovanni Faccini, Anna Fornasiero, Giorgio Talamini, Rosamaria Tommasoli, Enrico Arosio, Clara Lechi Santonastaso, Alessandro Lechi, and Carlo Patrono
Hypertension published December 1, 2003, doi:10.1161/01.HYP.0000105109.44620.1B [Abstract]  

Scientific Contributions
History of Hypertension and Enhanced Thrombogenic Activity in Postinfarction Patients

Yazid Y. Fadl, Wojciech Zareba, Arthur J. Moss, Victor J. Marder, Charles S. Sparks, Luc F. Miller Watelet, and Elizabeth R. Carroll
Hypertension 41: 943 -949; published online before print as doi:10.1161/01.HYP.0000061120.23237.D9 [Abstract] [Full text]  

Scientific Contributions
History of Hypertension and Enhanced Thrombogenic Activity in Postinfarction Patients

Yazid Y. Fadl, Wojciech Zareba, Arthur J. Moss, Victor J. Marder, Charles S. Sparks, Luc F. Miller Watelet, and Elizabeth R. Carroll
Hypertension published March 10, 2003, doi:10.1161/01.HYP.0000061120.23237.D9 [Abstract]  

Scientific Contributions
Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension: Relationship to Endothelial Dysfunction and Effects of Treatment

Dirk C. Felmeden, Charles G.C. Spencer, Andrew D. Blann, D. Gareth Beevers, and Gregory Y.H. Lip
Hypertension 41: 528 -533; published online before print as doi:10.1161/01.HYP.0000056997.40992.41 [Abstract] [Full text]  

Scientific Contributions
Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension. Relationship to Endothelial Dysfunction and Effects of Treatment

Dirk C. Felmeden, Charles G.C. Spencer, Andrew D. Blann, D. Gareth Beevers, and Gregory Y.H. Lip
Hypertension published February 24, 2003, doi:10.1161/01.HYP.0000056997.40992.41 [Abstract]  

Editorial Commentary
Hypertension, Platelets, and the Endothelium. The "Thrombotic Paradox" of Hypertension (or "Birmingham Paradox") Revisited

Gregory Y.H. Lip
Hypertension published February 3, 2003, doi:10.1161/01.HYP.0000049761.98155.7B [Abstract]  

Editorial Commentaries
Hypertension, Platelets, and the Endothelium: The "Thrombotic Paradox" of Hypertension (or "Birmingham Paradox") Revisited

Gregory Y.H. Lip
Hypertension 41: 199 -200; published online before print as doi:10.1161/01.HYP.0000049761.98155.7B [Full text]